Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-04-04Clinical Trial Update: Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating the combination of bortezomib and docetaxel in recurrent or metastatic head and neck cancer has completed; results …
-
CLINICAL_TRIALS trial_result · 2011-03-25Clinical Trial Update: Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase II study evaluating concurrent C225 (cetuximab), cisplatin, and radiation in stage IV head and neck squamous cell carcinoma completed …
-
CLINICAL_TRIALS research · 2011-03-23Clinical Trial Update: Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia [Phase 3]
Phase 3 clinical trial comparing parotid-sparing intensity-modulated radiation therapy with conventional radiation therapy for oropharyngeal…
-
CLINICAL_TRIALS trial_result · 2011-02-28Clinical Trial Update: Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating docetaxel and S-1 followed by radiation therapy and low-dose cisplatin in patients with stage III or IV head and ne…
-
CLINICAL_TRIALS trial_result · 2011-01-27Clinical Trial Update: ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer [Phase 2]
Phase 2 trial evaluating gefitinib (IRESSA) in combination with docetaxel and cisplatin for metastatic head and neck cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-01-20Clinical Trial Update: Magic Mouthwash Plus Sucralfate Versus Benzydamine Hydrochloride for the Treatment of Radiation-induced Mucositis [Phase 3]
Phase 3 trial comparing Magic Mouthwash plus sucralfate to benzydamine hydrochloride for radiation-induced mucositis in head and neck cancer…
-
CLINICAL_TRIALS research · 2010-12-24Clinical Trial Update: Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery [Phase 1, Phase 2]
Updates on a Phase 1/2 clinical trial evaluating celecoxib for patients with head and neck cancer that can be removed by surgery.
-
CLINICAL_TRIALS research · 2010-12-17Clinical Trial Update: An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of the radiotracer [18F]-ML-10 to detect tumor response to chemotherapy and radiot…
-
CLINICAL_TRIALS trial_result · 2010-12-13Clinical Trial Update: A Trial of Homeopathic Medication TRAUMEEL S for the Treatment of Radiation-Induced Mucositis [Phase 1]
Phase 1 trial evaluating TRAUMEEL S for radiation-induced mucositis in head and neck cancer has completed.
-
CLINICAL_TRIALS trial_result · 2010-10-19Clinical Trial Update: Endoscopy Screening for Esophageal Cancer
A clinical trial evaluating endoscopy screening for esophageal cancer has been terminated; the study lists head and neck cancer as a conditi…
-
CLINICAL_TRIALS research · 2010-10-07Clinical Trial Update: Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors [Phase 3]
A Phase 3 trial comparing intensity-modulated radiation therapy (IMRT) with 3-D conformal radiation therapy to reduce hearing loss after sur…
-
CLINICAL_TRIALS trial_result · 2010-09-23Clinical Trial Update: Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer [Phase 1]
Phase 1 trial evaluating postoperative radiotherapy with Iressa (gefitinib) in advanced head and neck cancer, with a comparison to radiother…
-
CLINICAL_TRIALS trial_result · 2010-09-06Clinical Trial Update: Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor [Phase 1]
Completed Phase 1 trial evaluating adaptive 18F-FDG-PET guided Biological Intensity-modulated Radiotherapy (BG-IMRT) in patients with head a…
-
CLINICAL_TRIALS withdrawal · 2010-08-26Clinical Trial Update: Transdermal Methylphenidate for Cancer-Related Fatigue [NA]
A clinical trial evaluating methylphenidate delivered via a transdermal patch for cancer-related fatigue in head and neck cancer patients ha…
-
CLINICAL_TRIALS trial_result · 2010-08-13Clinical Trial Update: S-Frame CT Immobilization Masks For Patients Undergoing Radiation Therapy For Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating S-Frame CT immobilization masks for patients undergoing radiation therapy for head and neck cancer has completed. T…
-
CLINICAL_TRIALS research · 2010-07-28Clinical Trial Update: Study of Biomarker From Blood and Tissue of Head and Neck Carcinoma
This document provides an update on a clinical trial investigating biomarkers from blood and tissue in head and neck cancer, including laryn…
-
CLINICAL_TRIALS trial_result · 2010-07-27Clinical Trial Update: Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast [NA]
This clinical trial update reports the completion of a study on indirect magnetic resonance lymphangiography of the head and neck using conv…
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED) [Phase 2]
A Phase 2 trial of temozolomide in pre-selected advanced aerodigestive tract cancers was terminated; results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-06-25Clinical Trial Update: Quality of Life in Patients Treated for Head and Neck Cancer
This ClinicalTrials.gov update describes quality-of-life outcomes observed in patients treated for head and neck cancer in study NCT00963586…
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating a regimen of chemotherapy plus gefitinib, followed by chemotherapy, radiation therapy, and gefitinib for head and n…
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer [Phase 2]
Phase 2 trial update for Combretastatin A4 Phosphate in advanced anaplastic thyroid carcinoma (a form of head and neck cancer); the study st…
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer [Phase 1, Phase 2]
A terminated Phase 1/2 trial evaluating induction chemotherapy with doxorubicin and cisplatin followed by combretastatin A4 phosphate and ra…
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck [Phase 1]
A Phase 1 study evaluating the combination of SU5416 and paclitaxel in patients with recurrent, locally advanced, or metastatic head and nec…
-
CLINICAL_TRIALS trial_result · 2010-06-07Clinical Trial Update: Real-Time Internet Evaluation of Swallowing
Clinical trial evaluating real-time internet-based swallowing assessment completed; results posted in 2010 for conditions including head and…
-
CLINICAL_TRIALS trial_result · 2010-05-21Clinical Trial Update: Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Phase 3]
A completed Phase 3 clinical trial evaluated radiation therapy plus porfiromycin for stage III or IV head and neck cancer, sponsored by Boeh…